Amelia joined the Parkinson’s Europe team in Jan 2022 as Research Manager. Since then she has developed Parkinson’s Europe’s Research Strategy, embedding a Research Steering Group into the organisation and helping to increase the presence of Parkinson’s Europe in the clinical research world. She is also focused on bringing new initiatives to the table, such as the Parkinson’s Europe’s Engagement Network, which better connects the Parkinson’s
community with research across Europe. Parkinson’s Europe is now a partner member of EUPATI and the Critical Path for Parkinson’s as part of this action.
She has been working in the field of Neurodegenerative research since 2009 and is a Patient Organisations board member with EUPATI since Sept 2023.
She previously worked for the UK NIHR’s DeNDRoN delivering clinical trials and then at Parkinson’s UK from July 2015 as Research Participation Lead. She was responsible for initiatives to increase research participation for people affected by Parkinson’s, health care professionals and researchers, and created the innovative Parkinson’s UK Take Part Hub and co-produced the Staying Connected toolkit in collaboration with the HRA UK.
Christian Milliet has over 25 years of experience in the pharma industry, leading Clinical Operations teams across Europe, USA, Latin America, China and Japan. His expertise encompasses all phases of drug development in a multitude of therapeutic areas.
He is currently Head of Site & Healthcare Ambassadors at CSL Behring. Previously, he worked for Vifor Pharma, Novartis, Serono and Covance.
In his current role, Christian is spearheading the development and expansion of site partnerships, leveraging CSL global presence. His focus is on creating strategic relationships to successfully deliver the CSL portfolio, including clinical development and real-world evidence.
Christian has a degree in Business Administration from Webster University in St. Louis, USA.
Stephanie is a Director in J&J’s Innovative Health Team, where she works to explore alternative options to traditional trial conduct in order to improve trial accessibility. Prior to joining Johnson & Johnson, she worked in Novartis’ Patient Experience team and spent 14 years as a management consultant with Accenture. American by birth, she has been living in Dublin, Ireland since 2016.
Deb Guattery most recently worked at Pfizer as the Process Lead for Home Health and Decentralized Clinical Trials. In that role, she built the processes and expanded the services of home nursing visits and other decentralized trial elements to be written into clinical trial protocols. Deb also advised in the writing of WCG Avoca Key Performance Indicators for the use of home health visits in a clinical trial and is an active participant in collaborative groups within the Decentralized Trials and Research Alliance (DTRA).
Deb continues to seek the advance of decentralized elements like the use of home health visits with the ultimate goal of driving better recruitment and retention of more diverse patients in clinical trials.
Ellen Weiss connects CROs and sponsors with right-sized hybrid and remote solutions. She has spoken on the logistical support necessary for IMP delivery and dosing, sample collection, and the services provided by clinical trial research nurses that enable alternate-site visits to be carried out with the same data quality and subject safety as on-site visits. Ellen is a member of the Healthcare Businesswomen’s Association and a volunteer for the American Society of Clinical Oncology.
Joonmi has 15+ years of experience in medical imaging and its application to clinical research and clinical trials. She is leading quantitative analysis and QC department and governing AI on delivery and R&D at Clario. Her experience includes product development, imaging protocol design, image processing algorithm and operational imaging service development. Joonmi has a Ph.D. degree in Electronical Engineering from University of Birmingham, UK.
Kate is a category and shopper expert. During her five years at Diageo, Kate was a key driver of the success of the Alcohol-free growth in GB. She has been instrumental in championing the Alcohol-free agenda and her efforts have notably improved Alcohol-Free point of purchase visibility.
